The current valuation score of Xenon Pharmaceuticals Inc is 8.71, ranking 93 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -11.24, which is -23.92% below the recent high of -8.55 and -74.03% above the recent low of -19.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.